Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PharmaMol
Saronno, Lombardy, Italypharmamol.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Pharmamol is a specialized biotechnology company based in Italy that focuses on computational drug discovery and molecular modeling services. The company provides advanced in silico solutions to pharmaceutical and biotech partners, including virtual screening, lead optimization, and ADME-Tox prediction. By leveraging high-performance computing and proprietary algorithms, Pharmamol aims to accelerate the early stages of drug development and improve the success rate of small molecule candidates. Their expertise spans across various therapeutic areas, supporting the design of novel chemical entities with optimized pharmacological profiles.
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on PharmaMol.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmaMol.